Redmile Group’s Xenon Pharmaceuticals XENE Stock Holding History

Redmile Group’s Portfolio XENE Stock Details XENE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$6M	Buy
2023 Q4	–	Sell
2023 Q3	$14.3M	Sell
2023 Q2	$43.1M	Sell
2023 Q1	$47.5M	Sell
2022 Q4	$93.1M	Sell
2022 Q3	$85.6M	Buy
2022 Q2	$49.9M	Buy